Furthermore, in a study by Yoo et al., 2022, Luteolin has been shown to inhibit the HCT116 colon cancer cells’ growth through p53-dependent regulation of apoptosis and cell cycle arrest, regardless of the autophagy induction [49]. The gene discussed is TP53; the disease is malignant colon neoplasm.